DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Pivot X, Romieu G, Bonnefoi H et al.
PHARE trial results of subset analysis comparing 6 to 12 months of trastuzumab
in adjuvant early breast cancer.
Cancer Res 2012;
72 (Suppl. 24) 104s
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.